Capitol Clarity / Firms / Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc. lobbies on its own behalf. For Q3 2026 it reported $1.45M across 1 client report and lists 5 lobbyists across its filings. Issues include Defense, Health Issues, Medicare/Medicaid and Taxation/Internal Revenue Code.

Clients, Q3 2026

ClientReportedIssues
TAKEDA PHARMACEUTICALS AMERICA INC$1.45MDefense, Health Issues, Medicare/Medicaid

By year

YearReportedClients
2026$3.47M1
2025$4.02M1

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.